Sunshine Biopharma files 8-K on offering closing
Sunshine Biopharma said it filed a Form 8-K with the SEC after issuing press releases on the pricing and closing of an offering.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sunshine Biopharma files 8-K on placement agreement
Sunshine Biopharma said it entered into a placement agent agreement with Aegis Capital Corp. for a best efforts public offering that closed Oct. 9. The company said gross proceeds were about $6 million before fees and expenses.